6.52
price down icon1.51%   -0.10
after-market アフターアワーズ: 6.60 0.08 +1.23%
loading

Insight Molecular Diagnostics Inc (IMDX) 最新ニュース

pulisher
Jan 31, 2026

Analysts Offer Insights on Healthcare Companies: Stryker (SYK), NewAmsterdam Pharma Company (NAMS) and Resmed (RMD) - The Globe and Mail

Jan 31, 2026
pulisher
Jan 28, 2026

Bullish Insight Molecular Diagnostics Insiders Rewarded As Their Investment Rises To US$8.13m - simplywall.st

Jan 28, 2026
pulisher
Jan 21, 2026

Analysts Offer Insights on Healthcare Companies: BillionToOne, Inc. Class A (BLLN) and Dexcom (DXCM) - The Globe and Mail

Jan 21, 2026
pulisher
Jan 14, 2026

IMDX Supports AST and ASHI STAR Working Group's Call for Decentralized Transplant Monitoring - marketscreener.com

Jan 14, 2026
pulisher
Jan 14, 2026

Insight ‘congratulated’ STAR working group on organ health testing paper - Yahoo Finance

Jan 14, 2026
pulisher
Jan 13, 2026

Analysts Offer Insights on Healthcare Companies: Inogen (INGN), Exelixis (EXEL) and Ultragenyx Pharmaceutical (RARE) - The Globe and Mail

Jan 13, 2026
pulisher
Jan 13, 2026

IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring - marketscreener.com

Jan 13, 2026
pulisher
Jan 13, 2026

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Boston Scientific (BSX) - The Globe and Mail

Jan 13, 2026
pulisher
Jan 07, 2026

iMDx Announces 'JPM Week” and 'BTIG Snowbird” Conference Participation - The Manila Times

Jan 07, 2026
pulisher
Jan 07, 2026

iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation - GlobeNewswire

Jan 07, 2026
pulisher
Jan 06, 2026

iMDx to Welcome Industry Veteran as Vice President of - GlobeNewswire

Jan 06, 2026
pulisher
Jan 06, 2026

iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch - Sahm

Jan 06, 2026
pulisher
Jan 06, 2026

Is Insight Molecular Diagnostics Inc. (7OC0) stock considered safe haven2026 world cup usa national team quarterfinals midfield engines low block defense group prediction preview - Улправда

Jan 06, 2026
pulisher
Jan 05, 2026

Needham reiterates Buy rating on Insight Molecular stock, cites progress on GraftAssureDx - Investing.com Nigeria

Jan 05, 2026
pulisher
Jan 05, 2026

Insight Molecular Diagnostics Inc. Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion - marketscreener.com

Jan 05, 2026
pulisher
Jan 05, 2026

Insight Molecular Diagnostics (IMDX) Nears Key FDA Submission Mi - GuruFocus

Jan 05, 2026
pulisher
Jan 05, 2026

IMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion - MarketScreener

Jan 05, 2026
pulisher
Jan 05, 2026

iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion - Sahm

Jan 05, 2026
pulisher
Jan 04, 2026

iMDx Stock Rebounds After-Hours As Study Shows Transplant Test Works As Well As Market Standard - MSN

Jan 04, 2026
pulisher
Dec 31, 2025

Prostate Cancer Diagnostics Market Size Report, 2026 – 2035 - Global Market Insights Inc.

Dec 31, 2025
pulisher
Dec 29, 2025

Insight Molecular Diagnostics Inc.Common Stock (NQ: IMDX - FinancialContent

Dec 29, 2025
pulisher
Dec 28, 2025

KIFFIK Biomedical Closes Oversubscribed Series A to Advance Real-Time Molecular Diagnostics Platform - newarkadvocate.com

Dec 28, 2025
pulisher
Dec 28, 2025

Insiders Rewarded With US$5.2m Addition To Investment As Insight Molecular Diagnostics Stock Hits US$183m - Yahoo Finance

Dec 28, 2025
pulisher
Dec 26, 2025

Molecular Cytogenetics Market Analysis Reveals Growth - openPR.com

Dec 26, 2025
pulisher
Dec 25, 2025

Insight Molecular (IMDX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 25, 2025
pulisher
Dec 24, 2025

Insight Molecular Diagnostics (FRA:7OC0) EV-to-OCF : -5.98 (As of Dec. 24, 2025) - GuruFocus

Dec 24, 2025
pulisher
Dec 24, 2025

Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), MDxHealth (MDXH) and RxSight (RXST) - The Globe and Mail

Dec 24, 2025
pulisher
Dec 23, 2025

Hedge funds investors control 50% of Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) and were rewarded last week after stock increased 11% - simplywall.st

Dec 23, 2025
pulisher
Dec 22, 2025

Animal Health Market Size, Share & Industry Trends Analysis Report [2032] - Fortune Business Insights

Dec 22, 2025
pulisher
Dec 19, 2025

Why Insight Molecular Diagnostics Inc. (7OC0) stock attracts HNW investorsQuarterly Risk Review & Verified Short-Term Trading Plans - DonanımHaber

Dec 19, 2025
pulisher
Dec 15, 2025

Biosensors Market Size, Share & Analysis | Growth Report [2032] - Fortune Business Insights

Dec 15, 2025
pulisher
Dec 13, 2025

United States Molecular Diagnostics Market Trends & Summary - vocal.media

Dec 13, 2025
pulisher
Dec 08, 2025

Page not foundFactor Thisâ„¢ - FinancialContent

Dec 08, 2025
pulisher
Dec 05, 2025

Is Insight Molecular Diagnostics Inc. (7OC0) stock suitable for passive index fundsJuly 2025 Update & Short-Term Trading Opportunity Alerts - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Is Insight Molecular Diagnostics Inc. (7OC0) stock a safe buy pre earningsMarket Sentiment Review & Safe Capital Preservation Plans - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will Insight Molecular Diagnostics Inc. (7OC0) stock sustain dividend payoutsOptions Play & Real-Time Volume Trigger Notifications - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Why global investors buy Insight Molecular Diagnostics Inc. (7OC0) stock2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Why Insight Molecular Diagnostics Inc. (7OC0) stock stays resilientMarket Movers & Real-Time Buy Zone Alerts - Newser

Dec 02, 2025
diagnostics_research WAT
$370.72
price down icon 1.19%
$144.81
price down icon 3.26%
diagnostics_research LH
$271.52
price up icon 0.63%
diagnostics_research MTD
$1,373.24
price down icon 1.40%
$231.14
price down icon 0.15%
diagnostics_research A
$133.85
price up icon 0.44%
大文字化:     |  ボリューム (24 時間):